Skip to content
Screener

LivaNova LIVN EPS (Diluted)

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.53-47.5%
Haemonetics logo
HaemoneticsHAE
$0.72+2.9%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$0.20+4.8%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$0.39-490%
Medtronic logo
MedtronicMDT
$0.97+18.3%
ITG
Integer HoldingsITGR
$0.48+173%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income (loss) before income tax18,47933,32045,964(282,326)
Income tax (benefit) expense(90,204)6,151(85,864)17,807
Loss from equity method investments(114)(8)(965)(28)
Net income (loss)$108,569$27,161$130,863$(300,161)
Basic earnings (loss) per share$1.98$0.50$2.39$(5.51)
Diluted earnings (loss) per share$1.93$0.50$2.33$(5.51)
Basic weighted average shares outstanding54,97154,57754,83154,502
Diluted weighted average shares outstanding56,27054,70856,10954,502

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's EPS (diluted)?
LivaNova (LIVN) reported EPS (diluted) of $1.93 in Q2 2026.
How has LivaNova's EPS (diluted) changed year-over-year?
LivaNova's EPS (diluted) increased by 286.0% year-over-year, from $0.50 to $1.93.
What is the long-term trend for LivaNova's EPS (diluted)?
Over 3 years (2021 to 2024), LivaNova's EPS (diluted) has grown at a -24.9% compound annual growth rate (CAGR), from -$2.72 to $1.15.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about LivaNova's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude